![Credit Card 160×600 [EN]](https://dcgreferral.com/wp-content/uploads/2024/05/US-Japan-and-German-April-Consumer-Confidence-Rebound-Orbex.webp.webp)
Similar Posts
Reversal Candlestick Patterns: Top Bullish & Bearish Reversal Candles | LiteFinance
2025.09.23 2025.09.23 Reversal Candlestick Patterns: Bullish and Bearish Reversal Candles Alan Tsagaraevhttps://www.litefinance.org/blog/authors/alan-tsagaraev/ Candlestick reversal patterns are important harbingers or rend reversals. These technical analysis tools can be used to predict price changes. These patterns form on an asset’s price chart and, depending on their type and shape, indicate potential upward or downward movement. These patterns…
Low-Drawdown Forex EA — Cap Drawdown Under 12 % (Live Proof)
Most EAs look good in backtests — until they drain your account live.This one capped drawdown under 12 % with +91 % real gain. Here’s how. Why Most Forex EAs Fail in Real Trading Backtest Deception vs. Real Drawdown Backtests can be seductive. You see a smooth curve, high returns, minimal risk — and you…
What Makes Breakeven Trades Good or Bad?
Our Forexpedia defines the breakeven point as the level where gains are equal to losses. A breakeven trade is one that is neither a winner nor a loser. It closes at a particular price where profit and loss are both equal to zero. Sure, you rarely get praise from others (as well as yourself) for…
Alpha Group International’s 2024 Revenue Jumps, Positive Momentum Continues into 2025
Alpha Group International reported a 23% rise in full-year revenue to £135.6 million for 2024, revealing strong growth across its divisions and a positive outlook for 2025. The financial solutions provider saw 20% organic revenue growth, excluding contributions from Cobase, which was acquired in late 2023. Revenue from the Private Markets (formerly labelled institutional) division…
ZBIO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma’s registration statement issued in connection with Zenas BioPharma’s initial public offering (“IPO”) held on or around September 13, 2024, and were damaged thereby,…
